Doravirine
Title | Journal |
---|---|
In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor. | Antimicrobial agents and chemotherapy 20140301 |
Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses. | Bioorganic & medicinal chemistry letters 20140201 |